2019: Phylogica Limited trading as PYC Therapeutics (ASX: PYC) ‘The Company’ or ‘PYC’ is pleased to announce the appointment of Dr. Fred K Chen to PYC’s Scientific Advisory Board (SAB). In addition to joining the SAB, Dr. Chen will also be the founding member of PYC’s Opthalmology Clinical Advisory Board – a specialist advisory board with the objective of guiding PYC’s ophthalmology pipeline through clinical evaluation.
Ann: Scientific Advisory Board Appointment, page-3
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $933.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12195 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 70252 | 1 |
View Market Depth
| Last trade - 10.02am 17/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |
Day chart unavailable